-
Classification of Deaths in Cardiovascular Outcomes Trials Known Unknowns and Unknown UnknownsMorrow DA, Wiviott SD. -
Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From the ACC’s Interventional Council and SCAIGP Frederick, AJ Kirtane and American College of Cardiology’s Interventional Council and the Society for Cardiovascular Angiography and Interventions.
-
In-Hospital Costs and Costs of Complications of Chronic Total Occlusion Angioplasty Insights From the OPEN-CTO RegistrySalisbury AC, Karmpaliotis D, Grantham JA et al.
-
Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-upIqbal J, Zhang YJ, Serruys PW et al.
-
Healthy Behavior, Risk Factor Control, and Survival in the COURAGE TrialDJ Maron, GBJ Mancini, COURAGE Trial Group et al.
-
Genetics and Causality of Triglyceride-Rich Lipoproteins in Atherosclerotic Cardiovascular DiseaseRosenson RS, Davidson MH, Hirsh BJ et al.
-
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsAntithrombotic Trialists’ (ATT) Collaboration.
-
Disrupting Fellow Education Through Group Texting: WhatsApp in Fellow Education?A Kochar, J Rymer, Duke Cardiovascular Education Group et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
